IMI impact on diabetes - Event
Start Date 08/06/2021About this event
IMI has a strong diabetes project portfolio, covering T1, T2 and diabetes complications, with several projects addressing different aspects of those diseases. Some are studying the underlying causes of the disease and the internal processes that lead to the destruction of the cells in the pancreas that produce insulin, in order to develop treatments. Others aim to detect clues as to how the disease will progress in different patients. Finally, many projects focus on detecting, preventing and treating the complications associated with diabetes.
This event was part of a series of live sessions that IMI is organising on IMI Impacts, where key actors explored the key challenges in their respective fields and demonstrate how IMI contributed. During these sessions, we also shared patients’ testimonies, as they are the ultimate beneficiaries of IMI’s funded research.
Furthermore, we engaged IMI stakeholders in a broader discussion on IMI’s impact. With this initiative, we demonstrated the successful IMI model of radical collaboration.
Find out more about...
IMI impact on diabetes
Outline of the event and presentations
Welcome and introduction by Magda Gunn, Scientific Project Manager, IMI |
|
Life with diabetes - patient testimonies by Veerle Vanhuyse, Communication Representative, INNODIA Presentation Recording Ken Tait, International diabetes advocate Presentation Recording
|
|
Highlights from IMI diabetes portfolio – paving the way for precision medicine and disease modifying therapies by Chantal Mathieu, Chair Endocrinology, University of Leuven Presentation Recording
Maria Gomez, Director, Lund University Diabetes Centre (LUDC), Lund University Presentation Recording Emma Ahlqvist, Associate Professor, Lund University Presentation Recording |
|
Q&A Time Recording
|
|
IMI Scientific Committee closing remarks by Eduard Montanya, Professor of Medicine at the University of Barcelona; Head of the Diabetes Section of Bellvitge University Hospital Recording |
Meet the speakers
Veerle Vanhuyse Communication Representative |
Ken Tait International diabetes advocate |
Chantal Mathieu Chair Endocrinology University of Leuven |
Maria Gomez Director, Lund University Diabetes Centre (LUDC) Lund University |
Emma Ahlqvist Associate Professor Lund University |
Eduard Montanya Professor of Medicine at the University of Barcelona; Head of the Diabetes Section of Bellvitge University Hospital |
Moderated by:
Magda Gunn Scientific Project Manager, IMI |